Section 5 of the Public Order Act 1986

Crypto Asset Trading Platform Bittrex and Former CEO to Settle SEC Charges for Operating an Unregistered Exchange, Broker, and Clearing Agency

Retrieved on: 
Thursday, August 10, 2023
Crypto, Joint Sigint Cyber Unit, Chris Carney, District court, Division, Security (finance), Section 5 of the Public Order Act 1986, Cryptocurrency, Bankruptcy

Washington D.C.--(Newsfile Corp. - August 10, 2023) - The Securities and Exchange Commission today announced that crypto asset trading platform Bittrex Inc. and its co-founder and former CEO, William Shihara, agreed to settle charges that they operated an unregistered national securities exchange, broker, and clearing agency.

Key Points: 
  • Washington D.C.--(Newsfile Corp. - August 10, 2023) - The Securities and Exchange Commission today announced that crypto asset trading platform Bittrex Inc. and its co-founder and former CEO, William Shihara, agreed to settle charges that they operated an unregistered national securities exchange, broker, and clearing agency.
  • Bittrex Inc.’s foreign affiliate, Bittrex Global GmbH, also agreed to settle charges that it failed to register as a national securities exchange.
  • It was supervised by Mark R. Sylvester, Jorge Tenreiro, and David Hirsch of the Crypto Assets and Cyber Unit.
  • Litigation in the bankruptcy court is being handled by Therese Scheuer and Patricia Schrage and supervised by Alistaire Bambach.

Takeda Receives FDA Approval to Expand the Use of HYQVIA® to Treat Primary Immunodeficiency in Children

Retrieved on: 
Tuesday, April 11, 2023
Nursing, Health, FDA, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Section 5 of the Public Order Act 1986, ASBIS, PI, TAK, Infection, Immunoglobulin G, Therapy, Patient, Immune system, Primary immunodeficiency, Observation, Diagnosis, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Vaccine, Takeda

Takeda ( TSE:4502/NYSE:TAK ) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) to expand the use of HYQVIA to treat primary immunodeficiency (PI) in children 2-16 years old.

Key Points: 
  • Takeda ( TSE:4502/NYSE:TAK ) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) to expand the use of HYQVIA to treat primary immunodeficiency (PI) in children 2-16 years old.
  • For example, intravenous route of administration may be difficult for some children and the frequency of some subcutaneous therapies may be challenging for some families’ schedules.2
    “Families of children living with primary immunodeficiency may feel overwhelmed by their child’s chronic medical needs.
  • Data were analyzed when all subjects completed 12 months of participation (one year of observation) in the trial.
  • During the 12-month trial period, HYQVIA was shown to be efficacious with respect to the occurrence of acute serious bacterial infections (aSBIs), a primary endpoint.

Lockridge Grindal Nauen P.L.L.P Announces Filing of Class Action Lawsuit Against BlockFi Individual Defendants Relating to BlockFi Interest Accounts

Retrieved on: 
Thursday, March 2, 2023
Person, Bias, BlockFi, Suite, Complaint, Court, Sale, Bankruptcy, Section 5 of the Public Order Act 1986, District court

1:23-cv-10472), on behalf of all persons or entities in the United States who invested in BlockFi Interest Accounts (“BIA”).

Key Points: 
  • 1:23-cv-10472), on behalf of all persons or entities in the United States who invested in BlockFi Interest Accounts (“BIA”).
  • The class period for the federal securities claims is March 4, 2019 to, and including, November 28, 2022.
  • BlockFi and their affiliates are presently subject to bankruptcy proceedings filed in November of 2022 and are not named as defendants in this action.
  • In addition, the Complaint alleges that BlockFi and the BlockFi Individual Defendants omitted and concealed material information concerning the risks associated with BIAs.

Think your company’s not covered by the FDCPA? You may want to think again.

Retrieved on: 
Tuesday, February 28, 2023
FDCPA, Comment, Blog, Green Tree, Pennsylvania, Policy, Collection, Federal Trade Commission Act of 1914, CPS, Privacy, Record, Creditor, Fair debt collection, FTC, Time, Commerce, Industry, Federal Trade Commission, Tax, Section 5 of the Public Order Act 1986, AMG, LLC, Leah, Fair Debt Collection Practices Act, Section 5, Communication, Language, Who, Fraud, Bank, Credit, Security (finance), Ditech
Key Points: 

FTC Releases Final Agenda for Feb. 16 Public Forum on Its Proposed Rule to Ban Noncompete Restrictions

Retrieved on: 
Monday, February 20, 2023
Federal Trade Commission Act of 1914, Comment, News, Social media, Section 5 of the Public Order Act 1986, EDT, FTC, Blog, Federal Trade Commission, Livestreaming

The Federal Trade Commission released the final agenda for the agency’s February 16 forum examining the FTC’s proposed rule to prohibit employers from imposing harmful noncompete restrictions on their workers.

Key Points: 
  • The Federal Trade Commission released the final agenda for the agency’s February 16 forum examining the FTC’s proposed rule to prohibit employers from imposing harmful noncompete restrictions on their workers.
  • The event will feature speakers who have been subjected to noncompete restrictions or otherwise have experience with noncompetes.
  • The FTC’s proposed rule generally would prohibit employers from using noncompete clauses, including independent contractors and anyone who works for an employer, whether paid or unpaid.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC Releases Final Agenda for Feb. 16 Public Forum on Its Proposed Rule to Ban Noncompete Restrictions

Retrieved on: 
Monday, February 20, 2023
Federal Trade Commission Act of 1914, Comment, News, Social media, Section 5 of the Public Order Act 1986, EDT, FTC, Blog, Federal Trade Commission, Livestreaming

The Federal Trade Commission released the final agenda for the agency’s February 16 forum examining the FTC’s proposed rule to prohibit employers from imposing harmful noncompete restrictions on their workers.

Key Points: 
  • The Federal Trade Commission released the final agenda for the agency’s February 16 forum examining the FTC’s proposed rule to prohibit employers from imposing harmful noncompete restrictions on their workers.
  • The event will feature speakers who have been subjected to noncompete restrictions or otherwise have experience with noncompetes.
  • The FTC’s proposed rule generally would prohibit employers from using noncompete clauses, including independent contractors and anyone who works for an employer, whether paid or unpaid.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC to Host Public Forum Examining Proposed Rule to Ban Noncompete Clauses

Retrieved on: 
Saturday, February 4, 2023
People, Comment, EDT, News, Social media, Federal Trade Commission, Section 5 of the Public Order Act 1986, Federal Trade Commission Act of 1914, FTC, Blog, Health insurance

The Federal Trade Commission will host a public forum on Thursday, February 16 examining the FTC’s proposed rule to prohibit employers from imposing noncompetes on their workers, and providing an opportunity for people to directly share their experiences with noncompetes.

Key Points: 
  • The Federal Trade Commission will host a public forum on Thursday, February 16 examining the FTC’s proposed rule to prohibit employers from imposing noncompetes on their workers, and providing an opportunity for people to directly share their experiences with noncompetes.
  • It will be webcast on the FTC’s website, transcribed, posted online, and included as part of the public record.
  • The FTC’s proposed rule generally would prohibit employers from using noncompete clauses, including independent contractors and anyone who works for an employer, whether paid or unpaid.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC to Host Public Forum Examining Proposed Rule to Ban Noncompete Clauses

Retrieved on: 
Saturday, February 4, 2023
People, Comment, EDT, News, Social media, Federal Trade Commission, Section 5 of the Public Order Act 1986, Federal Trade Commission Act of 1914, FTC, Blog, Health insurance

The Federal Trade Commission will host a public forum on Thursday, February 16 examining the FTC’s proposed rule to prohibit employers from imposing noncompetes on their workers, and providing an opportunity for people to directly share their experiences with noncompetes.

Key Points: 
  • The Federal Trade Commission will host a public forum on Thursday, February 16 examining the FTC’s proposed rule to prohibit employers from imposing noncompetes on their workers, and providing an opportunity for people to directly share their experiences with noncompetes.
  • It will be webcast on the FTC’s website, transcribed, posted online, and included as part of the public record.
  • The FTC’s proposed rule generally would prohibit employers from using noncompete clauses, including independent contractors and anyone who works for an employer, whether paid or unpaid.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

Administrative Law Judge Dismisses FTC Complaint Against Altria’s Minority Investment in JUUL

Retrieved on: 
Tuesday, February 15, 2022
Tobacco, Retail, Other Retail, ABI, NYSE, Altria Group, Inc. v. Good, PM, ALJ, Federal Trade Commission, AB InBev, John Middleton Co., Section 5 of the Public Order Act 1986, Philip Morris USA Inc. v. Williams, Smokeless tobacco, Clayton, Federal Trade Commission Act of 1914, Group, Facebook, Review, FTC, Vail v. Juul Labs, Inc., Adult, Ownership, United States courts of appeals, MST, Marlboro, MO, LinkedIn, General counsel, Juul, Twitter, Sherman, Helix, Investment, Smoker, Tobacco, JUUL, Altria, Cronos

Altria Group, Inc. (Altria) (NYSE: MO) today announces that an Administrative Law Judge (ALJ) dismissed the Federal Trade Commissions (FTC) claims against Altria and JUUL Labs, Inc. (JUUL) arising out of Altrias 2018 minority investment in JUUL.

Key Points: 
  • Altria Group, Inc. (Altria) (NYSE: MO) today announces that an Administrative Law Judge (ALJ) dismissed the Federal Trade Commissions (FTC) claims against Altria and JUUL Labs, Inc. (JUUL) arising out of Altrias 2018 minority investment in JUUL.
  • The ALJs decision is subject to review by the FTC.
  • Any decision by the FTC may be appealed to any U.S. Court of Appeals.
  • Altria also enhances its smoke-free product portfolio with exclusive U.S. commercialization rights to the IQOS Tobacco Heating System and Marlboro HeatSticks, and an equity investment in JUUL Labs, Inc. (JUUL).